Latest Strategic Asset Sales News

Vintage Energy reported a 24% drop in quarterly sales revenue to $0.9 million alongside a 20% production decline, while initiating a Production Uplift Program targeting its Southern Flank gas fields and maintaining steady 2P reserves at 12.5 MMboe.

Metal Hawk Limited has reported promising high-grade gold intersections from its maiden drilling campaign at Leinster South, alongside strategic asset sales that reshape its portfolio and bolster cash reserves.

Rapid Critical Metals has advanced its strategic silver portfolio in New South Wales through a $14 million capital raise, key acquisitions, and the start of drilling at its flagship projects, positioning itself for significant growth.

ActivEX Limited reports progress on multiple Queensland mineral projects, including a major drilling campaign at Gilberton and advancing rare earth exploration, while managing its portfolio through asset sales and loan facility extensions.

Alcoa Corporation reported a net income of $232 million for Q3 2025, driven by strategic asset sales and operational milestones including the permanent closure of its Kwinana alumina refinery and the sale of its Saudi Arabia joint venture stake.

Novo Resources Corp. reported a reduced net loss of CAD 9.7 million for the nine months to September 2025, supported by lower operating cash outflows and a significant post-period sale of San Cristobel Mining shares. The company maintains a cautious outlook amid ongoing funding needs.

Canadian Phosphate Limited has bolstered its balance sheet through the sale of its pelleting plant and reported improved cash flow despite permitting setbacks in British Columbia. The company is strategically positioned to capitalize on growing North American demand for domestically sourced phosphate amid global supply disruptions.

Alcoa Corporation reported a $232 million net income in Q3 2025 despite significant restructuring costs, driven by increased alumina and aluminum production and strategic asset sales.

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

Manhattan Corporation advances a high-resolution magnetic survey at its Hook Lake gold project in Nunavut while agreeing to sell its L3 Lithium Project in Nova Scotia for up to $1.34 million.

Synlait has agreed to sell its North Island assets to global healthcare giant Abbott for approximately US$178 million, marking a strategic reset focused on debt reduction and operational simplification. The deal, expected to close by April 2026, positions Synlait to concentrate on its South Island operations and explore new growth avenues.